Wisconsin Legislative Session Ends with Mixed Record on Cancer Policy
Statement from American Cancer Society Cancer Action Network (ACS CAN) Wisconsin Government Relations Director Sara Sahli
Statement from American Cancer Society Cancer Action Network (ACS CAN) Wisconsin Government Relations Director Sara Sahli
The following was originally published in the Empire Report on March 13, 2024.
DENVER, COLO. — MARCH 13, 2024 — American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Colorado convened at the State Capitol on Wednesday. They urged lawmakers to pass SB 124, which if enacted would ensure biomarker testing is covered by more insurance plans, including Health First Colorado, when supported by medical and scientific evidence.
The House Energy and Commerce Committee’s Subcommittee on Health today marked up the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, H.R. 3916. The bipartisan legislation would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2028.
West Virginia Can and Must Do Better to Boost Funding to Combat Tobacco Use, Protect Public Health
The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.
The American Cancer Society Cancer Action Network is Encouraged as Flawed Biomarker Legislation Does Not Pass
The Biden Cancer Moonshot announced today the expansion of coverage for patient navigation services in plans from seven health insurance companies.
La legislatura de Florida concluyó hoy su sesión de 2024 al aprobar un presupuesto que incluye fondos históricos para las prioridades del cáncer en estado, incluyendo aumentos significativos para el Fondo de Innovación contra el Cáncer de Florida.
Voluntarios y personal de ACS CAN y miembros de la Asociación Internacional de Bomberos, entregaron a las oficinas de Schumer y Jeffries más de 60,000 firmas en apoyo a la Ley de Detección Temprana de Múltiples Tipos de Cáncer Medicare.